Piramal Pharma Limited — Important, 27-01-2025: Updates

Piramal Pharma Limited has received a penalty of ₹15.44 crore under the Central Goods and Services Tax for alleged incorrect classification of goods, as per an order issued by the Additional Commissioner. It's important to note that this penalty was levied in the name of Piramal Enterprises Limited, relating to periods before the demerger of PEL and Piramal Pharma. The company is currently evaluating the order and plans to appeal within the specified timeframe. The potential financial impact of the penalty, if upheld, is limited to the amount levied, and it does not affect the company's operations. Investors should watch closely as the appeal process develops.